Jade Biosciences, Inc. (JBIO)
Latest JBIO Insider Trades
About Jade Biosciences, Inc. (JBIO)
Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. The company's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, and JADE301, an antibody candidate in preclinical development.
- WALTHAM, MA
- 55
- 2025
- XNAS
https://www.jadebiosciences.comSEC filings for JBIO on EDGAR
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 6 | 221,890 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
JBIO Insider Transactions (Form 4)
1813 Form 4 filings on record, the earliest from Apr 29, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mark Eisner | Grant or award | Stock Option (Right to Buy) | 47,675 | $0.00 |
Recent JBIO Form 8-K Filings
5JBIO Insider Trading - FAQ
What is the latest insider trade for JBIO?
Jade Biosciences, Inc. (JBIO) had 6 insider filings in the last 90 days, with the most recent on 2026-06-27. The full record for JBIO runs to 13 Form 4 filings, the earliest from 2025-04-29. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying JBIO stock?
No insider purchases of JBIO were filed in the last 90 days.
How many insiders are selling JBIO stock?
No insider sales of JBIO were filed in the last 90 days.
Where can I see JBIO SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks JBIO Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow JBIO insider buys?
Create a free InsiderAlpha account and press Watch on this page to add JBIO to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Mark Eisner view on EDGAR
- - Christopher W. Cain view on EDGAR
- - Eric Dobmeier view on EDGAR
- - Lawrence Otto Klein view on EDGAR
- - Erin Lavelle view on EDGAR
- - Fairmount Funds Management LLC view on EDGAR
- - Bradford D. Dahms view on EDGAR
- - Elizabeth Balta view on EDGAR
- - Tom Frohlich view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where JBIO's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track JBIO insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
